Furthermore, several studies reported the capacity of luteolin to inhibit STAT3 in different types of cancer cells, including breast, stomach, lung, liver, pancreas, cervix, and bile duct cancers [58,59,60,61,62,63,64]. This evidence concerns the gene STAT3 and bile duct cancer.